Stay updated on 3B-FOLFOX Combination Clinical Trial
Sign up to get notified when there's something new on the 3B-FOLFOX Combination Clinical Trial page.

Latest updates to the 3B-FOLFOX Combination Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the record history, and Revision: v3.4.1 along with related notices about funding and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a government funding notice banner and updated the page revision to v3.4.1, replacing the previous v3.4.0, with no changes to trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedUI updates add a glossary label, color-coding explanations, and a revision note (Revision: v3.4.0) with No FEAR Act data labeling. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check64 days agoChange DetectedA new Revision: v3.3.3 was added to the Record History and HHS Vulnerability Disclosure and Revision: v3.3.2 were removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Record History now shows a new revision entry labeled v3.3.2, with the earlier v3.2.0 entry removed; this is a routine maintenance/version update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedA new 'Study Status' entry has been added to the Record History page. The latest version (2025-11-07) documents current status updates for the trial.SummaryDifference1%

Stay in the know with updates to 3B-FOLFOX Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 3B-FOLFOX Combination Clinical Trial page.